Gadoversetamide is a gadolinium-based MRI contrast agent, particularly for imaging of the brain, spine and liver.[1][2] It is marketed under the trade name OptiMARK.
Notes
- ^ "Gadoversetamide Drug Information". Drugs.com. 2000-03-20. Archived from the original on 2007-10-10. Retrieved 2007-03-23.
- ^ Cheng KT (10 December 2007). "Gadoversetamide: Gd-DTPA-BMEA". Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US). PMID 20641436.